Viracta Therapeutics | 4:持股变动声明-高管 Faerm Michael E.
Viracta Therapeutics | 3:首次持股声明-高管 Faerm Michael E.
Viracta Therapeutics | 3:首次持股声明-高管 Burcar Melody
Viracta Therapeutics | 4:持股变动声明-高管 Rothera Mark
Viracta Therapeutics | 4:持股变动声明-高管 Cohen Darrel P.
Viracta Therapeutics | 4:持股变动声明-高管 Chevallard Daniel R.
Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-高管 Chevallard Daniel R.
Viracta Therapeutics | SC 13G:超过5%持股股东披露文件-Forward Ventures V, L.P.(6.65%)
Viracta Therapeutics | 4:持股变动声明-高管 Rothera Mark
Viracta Therapeutics | 4:持股变动声明-高管 Chevallard Daniel R.
Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-高管 Chevallard Daniel R.
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-高管 Cohen Darrel P.
Viracta Therapeutics | 3:首次持股声明-高管 Cohen Darrel P.
暂无数据